| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.004 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |